Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden. - Stone, Meredith L.; Chiappinelli, Katherine B.; Huili Li; Murphy, M.; Travers, Meghan E.; Topper, Michael J.; Baylin, Stephen B.; Zahnow, Cynthia A.; Mathios, Dimitrios; Michael Lim; Ie-Ming Shih; Tian-Li Wang; et al. (Proceedings of the National Academy of Sciences of the United States of America, 2017)